HRQoL in the Low MELD Pre-tx Population

NCT ID: NCT01573325

Last Updated: 2014-02-28

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-03-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to describe the HRQoL in those with MELD scores \</= 15 in a single center for those who are pre-liver transplant candidates

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The liver organ allocation system was significantly revised in 2002, allowing a more objective prioritization of liver transplant candidates. The revised Model for End Stage Liver Disease (MELD) system is based primarily on laboratory test results. Candidates with MELD scores of less than 15 are considered to be low priority for cadaveric liver transplant and have limited treatment options. Yet patients with low MELD scores may suffer from an array of symptoms associated with liver disease such as fatigue, sleep disturbances, and depression - all of which erode health-related quality of life (HRQoL). No previous studies were found that examined HRQoL in low MELD transplant patients. A better understanding of the HRQoL of these patients will allow clinicians to better meet their needs. Therefore, the aims of the proposed pilot capstone project are to examine HRQoL and to identify demographic and clinical characteristics including liver-disease related symptoms, functional status, perceived social support, biological functioning and mental health associated with HRQoL in pre-liver transplant candidates with low MELD scores. The revised Wilson and Cleary Quality of Life Model will be used to guide the project. Fifty pre-transplant liver candidates with MELD scores \< 15 will be enrolled in the descriptive, cross-sectional pilot study. Participants will complete a written questionnaire measuring perceived HRQoL and clinical characteristics. Descriptive and correlational statistics will be used to analyze the data. Findings from this project will identify trends in factors that contribute to a HRQoL of this population and provide the foundation for a larger future project.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cirrhosis of the Liver

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Cirrhosis of the liver Pre-liver transplant Candidate Depression Poor social support Liver disease symptoms Health releated quality of life

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Must be a patient in the liver transplant clinic at Northwestern Memorial Hospital or one of its satellite clinics (including Washington, Illinois; Portage, Indiana; Glenview, Illinois, Oakbrook, Illinois; Joliet, Illinois)
2. Adult patient between the ages of 18-75
3. Ability to read and speak English
4. Must be a candidate for liver transplant per Northwestern Memorial Hospital liver transplant multidisciplinary committee
5. Model for End Stage Liver Disease (MELD) score ≤15
6. Cognitive ability to complete measures

Exclusion Criteria

1. Non-English speaking
2. Those who have already received a liver transplant
3. Hepatic encephalopathy as evidenced by:

1. Grade II or more West Haven Criteria or Adapted West Haven Criteria
2. Evidence of Asterixis upon exam at time of consent (if consented in person)
4. Acute liver failure as etiology for liver disease.
5. MELD score \> 15
6. Mental retardation or cognitive disabilities preventing completion of the written questionnaire
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Loyola University

OTHER

Sponsor Role collaborator

Northwestern University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rebecca Duke

Transplant Surgery Nurse Practitioner

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rebecca Duke, MSN

Role: PRINCIPAL_INVESTIGATOR

Northwestern University

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STU00060397

Identifier Type: -

Identifier Source: org_study_id